Description
Retatrutide is an investigational synthetic peptide being studied for its interactions with GLP-1, GIP, and glucagon receptors.
It is currently in clinical trial phases internationally and holds no MHRA marketing authorisation.
Supplied as lyophilised powder, high purity, with batch CoA.
For licensed laboratory and in vitro research use only. Not for human consumption. Not a medicinal product.
Reviews
There are no reviews yet.